moxonidine has been researched along with Alloxan Diabetes in 2 studies
moxonidine: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sayed, SS | 1 |
| Zakaria, MN | 1 |
| Abdel-Ghany, RH | 1 |
| Abdel-Rahman, AA | 1 |
| Rupp, H | 1 |
| Elimban, V | 1 |
| Dhalla, NS | 1 |
2 other studies available for moxonidine and Alloxan Diabetes
| Article | Year |
|---|---|
Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats.
Topics: Adiponectin; Alkynes; Animals; Baroreflex; Blood Glucose; Body Weight; Cardiotonic Agents; Cystathio | 2016 |
Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcium-Transporting AT | 1994 |